Medifast Inc (MED) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Medifast Inc (MED) stock forecast summary
Our AI scores Medifast Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Medifast Inc is a small-cap company with a market capitalization of $142M.
For MED, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 46.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 13.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MED included.
MED price chart and AI forecast
How MED ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Medifast Inc (MED) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Miscellaneous Food Preparations & Kindred Products peers listed below that report each metric.
Valuation & Market
| Metric | MED | Rank |
|---|---|---|
| Market Cap | $142M | – |
| P/B Ratio | 0.79x | – |
| Dividend Yield | 0.51% | – |
| EPS | $-3.06 | – |
| Book Value/Share | $16.12 | – |
| Revenue/Share | $26.79 | – |
| FCF/Share | $-0.35 | – |
Profitability & Margins
| Metric | MED | Rank |
|---|---|---|
| ROE | -22.7% | – |
| ROA | -17.0% | – |
| ROIC | -17.6% | – |
| Gross Margin | 69.2% | – |
| Operating Margin | -11.6% | – |
| Net Margin | -13.6% | – |
| EBT Margin | -9.7% | – |
| Tax Rate | -40.1% | – |
Financial Health
| Metric | MED | Rank |
|---|---|---|
| Current Ratio | 4.82x | – |
| Quick Ratio | 4.32x | – |
| D/E Ratio | 0.33x | – |
| Financial Leverage | 1.33x | – |
| Interest Coverage | 585.2x | – |
| Working Capital | $160M | – |
Cash Flow
| Metric | MED | Rank |
|---|---|---|
| Operating Cash Flow | -$30K | – |
| Free Cash Flow | -$4M | – |
| Capital Spending | -$4M | – |
| OCF Growth YoY | -100.4% | – |
| FCF Growth YoY | -698.9% | – |
| FCF/Sales | -1.3% | – |
| CapEx/Sales | 1.3% | – |
Operational Efficiency
| Metric | MED | Rank |
|---|---|---|
| Asset Turnover | 1.25x | – |
| Inventory Turnover | 4.3x | – |
| Fixed Assets Turnover | 22.6x | – |
| Days Inventory | 84 days | – |
Income Statement
| Metric | MED | Rank |
|---|---|---|
| Total Revenue | $300M | – |
| Operating Income | -$35M | – |
| Net Income | -$41M | – |
| SG&A Expense | $242M | – |
| Cost of Goods Sold | $92M | – |
Dividend & Shareholder Information
| Metric | MED | Rank |
|---|---|---|
| Dividends Per Share | $0.07 | – |
| Shares Outstanding | 11M | – |
| Net Income Growth | -16639.3% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $202M | 84.3% of assets |
| Cash & Short-term Investments | $58M | 24.4% of assets |
| Inventory | $21M | 8.8% of assets |
| Total Liabilities | $59M | 24.8% of assets |
MED quarterly financials and insider trading
Medifast Inc (MED) industry peers
Companies classified under the same SEC industry code as Medifast Inc (Miscellaneous Food Preparations & Kindred Products): 4 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere MED sits on the market map
Medifast Inc (MED) stock news
Loading...
Medifast Inc (MED) stock forecast FAQ
What is the Medifast Inc (MED) stock forecast?
Our AI scores Medifast Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Medifast Inc stock predictions?
For MED, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 46.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 13.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Medifast Inc forecasts updated?
Medifast Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Medifast Inc's industry peers?
4 issuers in our coverage, MED included, share the SEC industry code Miscellaneous Food Preparations & Kindred Products. The largest are: Mccormick & Co Inc (MKC), Utz Brands, Inc. (UTZ), Coffee Holding Co Inc (JVA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.